Characteristics of the patients at diagnosis and response status at second transplantation in each group
| . | 2nd ASCT group, n = 85 . | Allo-RIC group, n = 25 . |
|---|---|---|
| Age)*, y (mean ± SD) | 55 ± 8 | 52 ± 6 |
| Hemoglobin, g/dL (mean ± SD) | 10.5 ± 2.3 | 9.9 ± 2 |
| Serum creatinine, mg/dL (mean ± SD) | 1.2 ± 0.9 | 0.9 ± 0.16 |
| Serum calcium, mg/dL (mean ± SD) | 9.6 ± 1.6 | 9.4 ± 0.65 |
| Albumin, g/dL (mean ± SD) | 3.5 ± 0.79 | 3.6 ± 0.7 |
| B2 microglobulin, mg/L (mean ± SD) | 3.9 ± 3.2 | 3 ± 1.3 |
| ISS | ||
| 1 | 31 | 11 |
| 2 | 39 | 9 |
| 3 | 13 | 1 |
| . | 2nd ASCT group, n = 85 . | Allo-RIC group, n = 25 . |
|---|---|---|
| Age)*, y (mean ± SD) | 55 ± 8 | 52 ± 6 |
| Hemoglobin, g/dL (mean ± SD) | 10.5 ± 2.3 | 9.9 ± 2 |
| Serum creatinine, mg/dL (mean ± SD) | 1.2 ± 0.9 | 0.9 ± 0.16 |
| Serum calcium, mg/dL (mean ± SD) | 9.6 ± 1.6 | 9.4 ± 0.65 |
| Albumin, g/dL (mean ± SD) | 3.5 ± 0.79 | 3.6 ± 0.7 |
| B2 microglobulin, mg/L (mean ± SD) | 3.9 ± 3.2 | 3 ± 1.3 |
| ISS | ||
| 1 | 31 | 11 |
| 2 | 39 | 9 |
| 3 | 13 | 1 |
ISS indicates International Staging System.
All P values were not significant except a trend for age (P = .07).